ver-of-intellectual-property-protection-for- covid-19-vaccines-11620243518> (5/5, Al, Hayashi, Hopkins, Subscription Publication, 8.41M) reports the Pharmaceutical Research and Manufacturers of America said the decision will weaken supply chains and increase counterfeiting. PhRMA said in a statement, "This decision does